An Italian randomised, double-blind placebo controlled study of the efficacy of Atomoxetine Hydrochloride in the treatment of children and adolescent with attention-deficit/hyperactivity disorder and Comorbid Oppositional Defiant Disorder.
| DEC-NET Serial number IT471 | |
| Published online | 14/09/2005 14.52.00 |
| Last updated | 14/09/2005 14.53.21 |
| Other protocol ID number | |
| Current trial status | Open (actively recruiting new participants) |
| Major Disease (ICD9 class) | ATTENTION DEFICIT DISORDER OF CHILDHOOD |
| Experimental drug | |
| Atomoxetina Cloridrato LY139603 | |
| Gender | Both |
| Age (range) | 6-15 years |
Eligibility criteria | |
Trial design/methodology | |
| Phase | 3 |
| Kind of study | Efficacy |
| Design | Controlled Randomised Blinded Double blind |
| Principal investigator | |
| Name | Prof. Alessandro Zuddas |
| Institution | Azienda ASL n. 8 . Clinica di Neuropsichiatria Infantile . Università di Cagliari |
| Postal address | Via Ospedale, 119 |
| City | Cagliari |
| Country | ITALY |
| Phone | |
| Fax | 070 669591 |
| azuddas@unica.it | |
| Sponsor name |
| Eli Lilly Italia SpA (Industry) |
| ISRCTN | EudraCT |
